Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride
- 1 January 1995
- journal article
- Published by Elsevier in Biomaterials
- Vol. 16 (2) , 145-148
- https://doi.org/10.1016/0142-9612(95)98278-m
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Chitosan matrix for oral sustained delivery of ampicillinBiomaterials, 1993
- Osteoconduction exerted by methylpyrrolidinone chitosan used in dental surgeryBiomaterials, 1993
- Controlled release of riboflavin and insulin through crosslinked poly(vinyl alcohol)/chitosan blend membraneJournal of Applied Polymer Science, 1992
- Permeability of vitamin B‐12 in chitosan membranes. Effect of crosslinking and blending with poly(vinyl alcohol) on permeabilityJournal of Applied Polymer Science, 1992
- Optimized Formulation of Magnetic Chitosan Microspheres Containing the Anticancer Agent, OxantrazolePharmaceutical Research, 1992
- Skin irritation and sensitizationJournal of Controlled Release, 1991
- Skin compatibility of transdermal drug delivery systemsJournal of Controlled Release, 1991
- Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of DapsoneJournal of Microencapsulation, 1991
- Investigation of Prolonged Drug Release from Matrix Formulations of ChitosanDrug Development and Industrial Pharmacy, 1990
- Contact dermatitis to transdermal estradiol systemJournal of the American Academy of Dermatology, 1989